Cargando…

Hypoxia Confers Tumor with a Higher Immune Infiltration but Lower Mutation Burden in Gastrointestinal Cancer

BACKGROUND: Hypoxia is one of the driving forces of cancer progression, recurrence, and metastasis. However, the association between the tumor hypoxic tumor microenvironment and the tumor mutation burden (TMB) is poorly understood in gastrointestinal cancer. METHODS: Approximately 2,000 samples from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Junjie, Hu, Wangxiong, Yang, Yanmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484921/ https://www.ncbi.nlm.nih.gov/pubmed/36131795 http://dx.doi.org/10.1155/2022/4965167

Ejemplares similares

Hypoxia Correlates With Poor Survival and M2 Macrophage Infiltration in Colorectal Cancer
por: Qi, Lina, et al.
Publicado: (2020)

Deciphering molecular properties of hypermutated gastrointestinal cancer
por: Hu, Wangxiong, et al.
Publicado: (2018)

A pretreatment transcriptomic signature that predicts outcomes of immunotherapy in melanoma
por: Hu, Junjie, et al.
Publicado: (2022)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
por: Wang, Kailai, et al.
Publicado: (2022)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma
por: Zhao, Yulan, et al.
Publicado: (2022)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023)

Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
por: Bi, Fangfang, et al.
Publicado: (2020)

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma
por: Ouyang, Rong, et al.
Publicado: (2021)

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
por: Steindl, A., et al.
Publicado: (2021)

CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu, Nan, et al.
Publicado: (2021)

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
por: Harbin, Laura M., et al.
Publicado: (2023)

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data
por: Liu, Shaoqing, et al.
Publicado: (2021)

Pan-organ transcriptome variation across 21 cancer types
por: Hu, Wangxiong, et al.
Publicado: (2016)

Comprehensive Analysis of the Relationships Between Tumor Mutation Burden With Immune Infiltrates in Cervical Cell Carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
por: Yin, Lu, et al.
Publicado: (2021)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
por: Wen, Fang, et al.
Publicado: (2021)

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma
por: Xie, Chan, et al.
Publicado: (2021)

A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma
por: Wang, Chengbang, et al.
Publicado: (2022)

Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma
por: Zhang, Siqin, et al.
Publicado: (2021)

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation
por: Fu, Jing, et al.
Publicado: (2021)

The influence of tumour mutational burden on renal cancer immune infiltration and survival
por: Byrne, Matthew H. V., et al.
Publicado: (2020)

Gene expression and immune infiltration in melanoma patients with different mutation burden
por: Wang, Liwei, et al.
Publicado: (2021)

The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
por: Yuan, Cheng, et al.
Publicado: (2020)

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
por: Cui, Shengjin, et al.
Publicado: (2023)

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023)

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
por: Kim, Samuel I., et al.
Publicado: (2021)

Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer
por: Jiang, Ai-Min, et al.
Publicado: (2021)

YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma
por: Lin, Xiangan, et al.
Publicado: (2020)

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
por: Wang, Haoyu, et al.
Publicado: (2022)

Higher Mutation Burden in High Proliferation Compartments of Heterogeneous Melanoma Tumors
por: Grzywa, Tomasz M., et al.
Publicado: (2021)

Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor
por: Wang, Jingjing, et al.
Publicado: (2021)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
por: Yan, Junya, et al.
Publicado: (2020)

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2021)

ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration
por: Wang, Jia, et al.
Publicado: (2020)

NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden
por: Li, Zihao, et al.
Publicado: (2023)

Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability
por: Yang, Dongdong, et al.
Publicado: (2021)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2lpmq77e9rhapt6qbok2tld84g